Changes in brain insulin metabolism and insulin resistance are associated with several CNS disorders such as Alzheimers disease (AD), depression [71,72,73], autism [74], schizophrenia [75], Huntingtons disease [76], Parkinsons disease (PD) [77], etc
Everyone's talking about them, but the phrase can be misleading, especially as the market expands
Despite this relative decline, NAEs persisted as a substantial AE subset, maintaining notable absolute reporting frequencies during the final three observation years (20212024) (Fig
Combining it with another GLP-1 or GIP agonist (semaglutide, tirzepatide) would compound the same receptor load and the same GI and hypoglycemia risks with no efficacy evidence to support it
24:53 Dr